Innate immune defense in visceral leishmaniasis: Cytokine mediated protective role by allogeneic effector cell

Vaccine

Volumn 28, Issue 3, 2010, Pages 803-810

  Manna, Partha Pratim ^a   Chakrabarti, Ganes ^b   Bandyopadhyay, Santu ^b  

^a BANARAS HINDU UNIVERSITY   (India)

^b INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

Author keywords

Adoptive cell therapy; Leishmania; NK cell; TNF

Indexed keywords

GAMMA INTERFERON; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIPROTOZOAL ACTIVITY; ARTICLE; CELL ADHESION; CELL MEDIATED CYTOTOXICITY; CELL THERAPY; COCULTURE; CONTROLLED STUDY; EFFECTOR CELL; FEMALE; HUMAN; HUMAN CELL; INNATE IMMUNITY; LEISHMANIA DONOVANI; MACROPHAGE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROMASTIGOTE; VISCERAL LEISHMANIASIS;

ANIMALS; CELL ADHESION; CELLS, CULTURED; COCULTURE TECHNIQUES; FEMALE; IMMUNITY, INNATE; IMMUNOTHERAPY; INTERFERON-GAMMA; KILLER CELLS, NATURAL; LEISHMANIA DONOVANI; LEISHMANIASIS, VISCERAL; MACROPHAGES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; SPLEEN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 71149113856     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.10.053     Document Type: Article

References (32)

1. Carvalho E.M., Bacellar O., Barral A., Badaro R., and Johnson Jr. W.D. Antigen specific immunosuppression in visceral leishmaniasis is cell mediated. J Clin Invest 83 (1989) 860-864
2. Carvalho E.M., Teixeira R.S., and Watson Jr. W.D. Cell mediated immunity in American visceral leishmaniasis: reversible immunosuppression during acute infection. Infect Immun 33 (1981) 498-500
3. Badaro R., Jones T.C., Carvalho E.M., Sampaio D., Reed S.G., Barral A., et al. New perspectives on a subclinical form of visceral leishmaniasis. J Infect Dis 154 (1986) 1003-1011
4. Murray H.W., Masur H., and Keithly J.S. Cell mediated immune responses in experimental visceral leishmaniasis. I. Correlation between resistance to Leishmania donovani and lymphokine generating capacity. J Immunol 129 (1982) 344-350
5. Squires K.E., Schreiber R.D., McElrath M.J., Rubin B.Y., Anderson S.L., and Murray H.W. Experimental visceral Leishmaniasis: role of endogenous IFN-g in host defenses and tissue granulomatous response. J Immunol 143 (1989) 4244-4249
6. Murray H.W. Endogenous IL-12 regulates acquired resistance in experimental visceral Leishmaniasis. J Infect Dis 175 (1997) 1477-1479
7. Green S.J., Crawford R.M., Hockmeyer J.T., Meltzer M.S., and Nacy C.A. Leishmania major amastigotes initiate the l-arginine-dependent killing mechanism in IFN-γ stimulated macrophages by induction of tumor necrosis factor-α. J Immunol 145 (1990) 4290-4297
8. Beutler B., and Grau G.E. Tumor necrosis factor in the pathogenesis of infectious diseases. Crit Care Med 21 (1993) S423-S435
9. Vassali P. The pathophysiology of tumor necrosis factors. Annu Rev Immunol 10 (1992) 411-452
10. Nashleanas M., Kanaly S., and Scott P. Control of Leishmania major infection in mice lacking TNF receptors. J Immunol 160 (1998) 5506-5513
11. Yap G.S., Scharton-Karsten T., Charest H., and Sher A. Decreased resistance of TNF receptor p55- and p75-deficient mice to chronic toxoplasmosis despite normal activation of inducible nitric oxide synthase in vivo. J Immunol 160 (1998) 1340-1345
12. Vieira L., Goldschmidt Q.M., Nashleanas M., Pfeffer K., Mak T., and Scott P. Mice lacking TNF-receptor p55 fails to resolve lesions caused by infection with Lesihmania major, but control parasite replication. J Immunol 157 (1996) 827-835
13. Flynn J.L., Goldstein M.M., Chan J., Triebold K.J., Pfeffer K., Lowenstein C.J., et al. Tumor necrosis factor-α is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity 2 (1995) 561-572
14. Rothe J., Lesslauer W., Loetscher H., Lang Y., Koebel P., Koentgen F., et al. Mice lacking the tumor necrosis factor receptor 1 are resistant to TNF mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature 364 (1993) 798-802
15. Ehlers S., Benini L., Kutsch S., Enders R., Rietschel E.T., and Pfeffer K. Fatal granuloma necrosis without exacerbated mycobacterial growth in tumor necrosis factor receptor p55 gene deficient mice intravenously infected with Mycobacterium avium. Infect Immun 67 (1999) 3571-3579
16. Dekert-Schluter M., Bluethmann H., Rang A., Hof H., and Schluter D. Crucial role of TNF receptor type 1 (p55) but not of TNF receptor type 2 (p75) in murine toxoplasmosis. J Immunol 160 (1998) 3427-3436
17. Taylor A., and Murray H.W. Intracellular antimicrobial activity in the absence of interferon-γ: effect of interleukin-2 in experimental visceral leishmaniasis in IFN-γ gene disrupted mice. J Exp Med 185 (1997) 1231-1239
18. Tumang M.C., Keogh T.C., Moldawer L.L., Helfgott D.C., Teitlbaum R., Hariprashad J., et al. Role and effect of TNF-α in experimental visceral leishmaniasis. J Immunol 153 (1994) 768-775
19. Ghosh A.K., Bhattacharyya F.K., and Ghosh D.K. Leishmania donovani: amastigote inhibition and mode of action of berberine. Exp Parasitol 60 (1985) 404-413
20. Saha B., Roy H.N., Pakrashi A., Chakrabarti R.N., and Roy S. Immunobiological studies on experimental visceral leishmaniasis I. Changes in lymphoid organs and their possible role in pathogenesis. Eur J Immunol 21 (1991) 577-581
21. Reiner N.E., Ng W., Wilson C.B., Macmaster W.R., and Burchett S.K. Modulation of in vitro monocyte cytokine responses to Leishmania donovani. Interferon gamma prevents parasite-induced inhibition of interleukin-1 production and prime monocytes to respond to Lesihmania by producing both tumor necrosis factor-alpha and interleukin 1. J Clin Invest 85 (1990) 1914-1924
22. Wilhelm P., Ritter U., Labbow S., Donhauser N., Rollinghoff M., Bogdan C., et al. Rapidly fatal leishmaniasis in resistant C57BL/6 mice lacking TNF. J Immunol 166 (2001) 4012-4019
23. Theodos C., Povinelli M.L., Mollina R., Sherry B., and Titus R.G. Role of tumor necrosis factor in macrophage leishmanicidal activity in vitro and resistance to cutaneous leishmaniasis in vivo. Infect Immun 59 (1991) 2839-2842
24. Kriegler M., Perez C., Defay K., Albert I., and Lu S.D. A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: ramification for the complex physiology of TNF. Cell 53 (1988) 45-53
25. Perez C., Albert I., Defay K., Zachariades N., Gooding L., and Kriegler M. A nonsecretable cell surface mutant of tumor necrosis factor (TNF) kills by cell-to-cell contact. Cell 63 (1990) 251-258
26. + T lymphocyte plasma membrane. J Exp Med 174 (1991) 755-759
27. + T cell subsets and induces early resistance to Leishmania major in mice. J Exp Med 178 (1993) 567-577
28. Manna P.P., Bharadwaj D., Bhattacharya S., Chakrabarti G., Basu D., Mallick K.K., et al. Impairment of natural killer cell activity in Indian kala-azar: restoration of activity by interleukin 2 but not by alpha or gamma interferon. Infect Immun 61 (1993) 3565-3569
29. + T helper cell function in HIV-infected individuals by stimulation with HLA alloantigens. J Immunol 144 (1990) 3266-3271
30. Childs R., Chernoff A., Contentin N., Bahceci E., Schrump D., Leitman S., et al. Regression of metastatic renal-cell carcinoma after nomyeloobletive allogeneic peripheral blood stem cell transplantation. N Engl J Med 343 (2000) 750-758
31. Ueno N.T., Cheng Y.C., Rondón G., Tannir N.M., Gajewski J.L., Couriel D.R., et al. Rapid induction of complete donor chimerism by the use of a reduced intensity conditioning regimen composed of fluderabin and melphalan in allogeneic stem cell transplantation for metastatic solid tumors. Blood 102 (2003) 3829-3836
32. Bethge W.A., Hegenbart U., Stuart M.J., Storer B.E., Maris M.B., Flowers M.E., et al. Adoptive immunotherapy with donor lymphocyte infusions after allogeneic haematopoietic stem cell transplantation following nonmyeloobletive conditioning. Blood 103 (2004) 790-795